Abstract
Introduction
Berardinelli-Seip syndrome or congenital generalized lipodystrophy type 2 is a rare genetic disorder characterized by selective loss of subcutaneous adipose tissue associated with peripheral insulin resistance and its complications. Nonprogressive mental retardation, dystonia, ataxia, and pyramidal signs are commonly present, whereas epilepsy has only occasionally been observed.
Case report
We report the case of two sisters, 11 and 18 years old respectively, with an overlapping clinical phenotype compatible with Berardinelli-Seip syndrome and progressive myoclonic epilepsy. Molecular analysis identified an autosomal recessive c.1048C > t;(p(Arg350*)) pathogenic mutation of exon 8 of the BSCL2 gene, which was present in a homozygous state in both patients.
Conclusions
Our paper contributes to further delineate a complex phenotype associated with BSCL2 mutation, underlining how seipin has a central and partially still unknown role that goes beyond adipose tissue metabolism, with a prominent involvement in central nervous system pathology.
References
Patni N, Garg A (2015) Congenital generalized lipodystrophies—new insights into metabolic dysfunction. Nat Rev Endocrinol 11(9):522–534. https://doi.org/10.1038/nrendo.2015.123
Opri R, Fabrizi GM, Cantalupo G, Ferrarini M, Simonati A, Dalla Bernardina B, Darra F (2016) Progressive myoclonus epilepsy in congenital generalized lipodystrophy type 2: report of 3 cases and literature review. Seizure. 42:1–6. https://doi.org/10.1016/j.seizure.2016.08.008
Lima JG, Nobrega LH, de Lima NN, do Nascimento Santos MG, Baracho MF, Jeronimo SM (2016) Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetol Metab Syndr 8:23. https://doi.org/10.1186/s13098-016-0140-x
Tseng CF, Ho CS, Chiu NC, Lin SP, Tzen CY, Wu YH (2009) Lafora disease and congenital generalized lipodystrophy: a case report. Kaohsiung J Med Sci 25(12):663–668. https://doi.org/10.1016/S1607-551X(09)70572-8
Guillén-Navarro E, Sánchez-Iglesias S, Domingo-Jiménez R, Victoria B, Ruiz-Riquelme A, Rábano A, Loidi L, Beiras A, González-Méndez B, Ramos A, López-González V, Ballesta-Martínez MJ, Garrido-Pumar M, Aguiar P, Ruibal A, Requena JR, Araújo-Vilar D (2013) A new seipin-associated neurodegenerative syndrome. J Med Genet 50(6):401–409. https://doi.org/10.1136/jmedgenet-2013-101525
Serino D, Davico C, Specchio N, Marras CE, Fioretto E (2019) Berardinelli-Seip syndrome and progressive myoclonus epilepsy. Epileptic Disord 21(1):117–121. https://doi.org/10.1684/epd.2019.1038
Ebihara C, Ebihara K, Aizawa-Abe M, Mashimo T, Tomita T, Zhao M, Gumbilai V, Kusakabe T, Yamamoto Y, Aotani D, Yamamoto-Kataoka S, Sakai T, Hosoda K, Serikawa T, Nakao K (2015) Seipin is necessary for normal brain development and spermatogenesis in addition to adipogenesis. Hum Mol Genet 24(15):4238–4249. https://doi.org/10.1093/hmg/ddv156
Garfield AS, Chan WS, Dennis RJ, Ito D, Heisler LK, Rochford JJ (2012) Neuroanatomical characterisation of the expression of the Lipodystrophy and motor-neuropathy gene Bscl2 in adult mouse brain. PLoS One 7(9):e45790. https://doi.org/10.1371/journal.pone.0045790
Sánchez-Iglesias S, Fernández-Liste A, Guillín-Amarelle C, Rábano A, Rodriguez-Cañete L, González-Méndez B, Fernández-Pombo A, Senra A, Araújo-Vilar D (2019) Does seipin play a role in oxidative stress protection and peroxisome biogenesis? New insights from human brain autopsies. Neuroscience 396:119–137. https://doi.org/10.1016/j.neuroscience.2018
Kälviäinen R (2015) Progressive myoclonus epilepsies. Semin Neurol 35(3):293–299. https://doi.org/10.1055/s-0035-1552620
Funding
The authors received no funding for this work. The work described has not been published before, and it is not under consideration for publication anywhere else.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Its publication has been approved by all co-authors, as well as by the responsible authorities at the institute where the work has been carried out.
Informed consent
Informed consent was obtained from the patient’s parents.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ferranti, S., Lo Rizzo, C., Renieri, A. et al. Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome. Neurol Sci 41, 3345–3348 (2020). https://doi.org/10.1007/s10072-020-04418-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04418-1